Belite Bio (BLTE) Reports In-Line Q4 EPS
Belite Bio (NASDAQ: BLTE) reported Q4 EPS of ($0.32), in-line with the analyst estimate of ($0.32).
For earnings history and earnings-related data on Belite Bio (BLTE) click here.
Belite Bio (NASDAQ: BLTE) reported Q4 EPS of ($0.32), in-line with the analyst estimate of ($0.32).
For earnings history and earnings-related data on Belite Bio (BLTE) click here.